Risk Factors for High-Risk Human Papillomavirus Infection and Cofactors for High-Grade Cervical Disease in Peru

被引:20
|
作者
Almonte, Maribel [1 ]
Ferreccio, Catterina [2 ]
Gonzales, Miguel [3 ,4 ]
Delgado, Jose Manuel [4 ,5 ]
Buckley, C. Hilary [6 ]
Luciani, Silvana [4 ]
Robles, Sylvia C. [4 ]
Winkler, Jennifer L. [7 ]
Tsu, Vivien D. [7 ]
Jeronimo, Jose [7 ]
Cuzick, Jack [1 ]
Sasieni, Peter [1 ]
机构
[1] Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Canc Prevent, London EC1M 6BQ, England
[2] Pontificia Univ Catolica Chile, Santiago, Chile
[3] Direcc Reg Salud DIRES San Martin, Tarapoto, Peru
[4] Pan Amer Hlth Org, Washington, DC USA
[5] Univ Nacl San Martin, Tarapoto, Peru
[6] St Marys Hosp, Dept Pathol, Manchester M13 0JH, Lancs, England
[7] PATH, Seattle, WA USA
关键词
Human papillomavirus; Cervical cancer; Cervical screening; Risk factors; POOLED ANALYSIS; HPV INFECTION; WOMEN; CANCER; PREVALENCE; NEOPLASIA; EPIDEMIOLOGY; CYTOLOGY; AGE;
D O I
10.1097/IGC.0b013e3182288104
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To evaluate the association between potential risk factors for high-risk human papillomavirus (HR-HPV) infection and cofactors for cervical intraepithelial lesions grade 2 or worse (CIN2+) in women attending cervical screening in Amazonian Peru. Materials and Methods: Participants completed a risk factor questionnaire before screening. High-risk human papillomavirus infection was determined by Hybrid Capture II. Logistic regression was used to evaluate associations between potential risk factors for HR-HPV infection and between cofactors and risk of CIN2+ among women with HR-HPV infection. Results: Screening and questionnaires were completed by 5435 women aged 25 to 49 years. The prevalence of HR-HPV was 12.6% (95% confidence interval [CI], 11.8%-13.6%) and decreased by age. Early age at first sexual intercourse and several lifetime sexual partners increased the risk of having HR-HPV (age-adjusted odds ratio [AOR] of age at first sexual intercourse <18 vs >= 20, 1.5; 95% CI, 1.2-2.0; AOR of >= 5 lifetime sexual partners vs 1, 2.1; 95% CI, 1.4-3.2). Among women with HR-HPV infection, those with no schooling (AOR relative to 1-5 years of schooling, 3.2; 95% CI, 1.3-8.3) and those with parity >= 3 (AOR relative to parity <3, 2.6; 95% CI, 1.4-4.9) were at increased risk of CIN2+. The effect of parity was stronger for cancer (AOR of parity >= 3 vs <3, 8.3; 95% CI, 1.0-65.6). Further analysis showed that the association between parity and CIN2+ was restricted to women younger than 40. Most women (83%) had previously been screened. Sixty-four percent of CIN2+ cases detected in this study occurred in women who reported having had a Papanicolaou test in the previous 3 years. Only 4 of 20 cancers were detected in women never screened before. Having had a previous abnormal Papanicolaou test increased the risk of CIN2+ (OR, 16.1; 95% CI, 6.2-41.9). Conclusion: Among women with HR-HPV, high parity (in young women), no schooling, lack of good-quality screening and of adequate follow-up care are the main risk factors for high-grade cervical disease in Peru.
引用
收藏
页码:1654 / 1663
页数:10
相关论文
共 50 条
  • [1] Factors associated with high-risk human papillomavirus infection and high-grade cervical neoplasia: A population-based study in Paraguay
    Kasamatsu, Elena
    Rodriguez Riveros, Maria Isabel
    Maria Soilan, Ana
    Ortega, Marina
    Mongelos, Pamela
    Paez, Malvina
    Castro, Amalia
    Cristaldo, Carmen
    Romina Baez, Fatima
    Carolina Centurion, Claudia
    Vester, Jaime
    Barrios, Hernan
    Villalba, Griselda
    Luisa Amarilla, Maria
    Gimenez, Graciela
    Caubere, Elodie
    Hernandez, Maria de la Luz
    Baena, Armando
    Almonte, Maribel
    Herrero, Rolando
    Patricia Mendoza, Laura
    Patricia Mendoza, Laura
    Kasamatsu, Elena
    Rodriguez Riveros, Maria Isabel
    Maria Soilan, Ana
    Ortega, Marina
    Mongelos, Pamela
    Paez, Malvina
    Castro, Amalia
    Cristaldo, Carmen
    Romina Baez, Fatima
    Carolina Centurion, Claudia
    Vester, Jaime
    Barrios, Hernan
    Villalba, Griselda
    Luisa Amarilla, Maria
    Gimenez, Graciela
    PLOS ONE, 2019, 14 (06):
  • [2] High-risk human papillomavirus DNA testing and high-grade cervical intraepithelial lesions
    You, Ke
    Liang, Xueai
    Qin, Fengjin
    Guo, Yanli
    Geng, Li
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2007, 47 (02): : 141 - 144
  • [3] The prevalence and risk factors of anal human papillomavirus infection in high-grade cervical intraepithelial neoplasia patients
    Alksnite, A.
    Caica-Rinca, A.
    Priedite, M.
    Zodzika, J.
    Osite, J.
    Bordo, Z.
    Lietuviete, N.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 270 : E49 - E50
  • [4] Chromosomal profiles of high-grade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection
    Bierkens, Mariska
    Wilting, Saskia M.
    van Wieringen, Wessel N.
    van Kemenade, Folkert J.
    Bleeker, Maaike C. G.
    Jordanova, Ekaterina S.
    Bekker-Lettink, Marjolein
    van de Wiel, Mark A.
    Ylstra, Bauke
    Meijer, Chris J. L. M.
    Snijders, Peter J. F.
    Steenbergen, Renske D. M.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (04) : E579 - E585
  • [5] High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia
    Jeong, Nan Hee
    Lee, Nak Woo
    Kim, Hai Joong
    Kim, Tak
    Lee, Kyu Wan
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2009, 35 (04) : 706 - 711
  • [6] Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease
    Joura, Elmar A.
    Ault, Kevin A.
    Bosch, F. Xavier
    Brown, Darron
    Cuzick, Jack
    Ferris, Daron
    Garland, Suzanne M.
    Giuliano, Anna R.
    Hernandez-Avila, Mauricio
    Huh, Warner
    Iversen, Ole-Erik
    Kjaer, Susanne K.
    Luna, Joaquin
    Miller, Dianne
    Monsonego, Joseph
    Munoz, Nubia
    Myers, Evan
    Paavonen, Jorma
    Pitisuttithum, Punnee
    Steben, Marc
    Wheeler, Cosette M.
    Perez, Gonzalo
    Saah, Alfred
    Luxembourg, Alain
    Sings, Heather L.
    Velicer, Christine
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (10) : 1997 - 2008
  • [7] Treatment with paiteling for cervical high-risk human papillomavirus infection
    Tao, Pingping
    Meng, Xiaohua
    Chen, Junxia
    Sun, Aijing
    Shou, Qinghe
    Yang, Binlie
    Zheng, Weiping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (05): : 4912 - 4918
  • [8] Genetic risk prediction of high-risk human papillomavirus infection and cervical cancer
    Laisk, Triin
    Lall, Kristi
    Tisler, Anna
    Ojavee, Sven Erik
    Uuskula, Anneli
    Gualdo, Natalia Pujol
    Magi, Reedik
    HUMAN HEREDITY, 2023, 88 (SUPPL 1) : 22 - 22
  • [9] Coinfection of High-Risk Human Papillomavirus and Lower Genital Tract Pathogens in the Development of High-Grade Cervical Lesions
    Zhong, Hui
    Tong, Yao
    Lin, Haifeng
    Mao, Xiaodan
    Dong, Binhua
    Wu, Zhihui
    Chen, Huiyu
    Sun, Pengming
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2020, 2020
  • [10] Risk factors for high-risk human papillomavirus cervical infection and clearance in patients with systemic lupus erythematosus
    Goulenok, Tiphaine
    Ferre, Valentine Marie
    Mageau, Arthur
    Papo, Thomas
    Sacre, Karim
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 116 : 149 - 151